Oorsprong van het eerstegraads netwerk van Andrew Muratore
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 16 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andrew Muratore via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Bristol | College/University | Doctorate Degree | |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | President | |
| Universität des Saarlandes | College/University | Doctorate Degree | |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | Corporate Officer/Principal | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director of Finance/CFO | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Chief Executive Officer | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chief Executive Officer | |
| London Business School | College/University | Masters Business Admin | |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Founder | |
Franklin Templeton Investments Corp.
 Franklin Templeton Investments Corp. Investment ManagersFinance Franklin Templeton Investments Corp. (FTI) is a SEC-registered investment advisor and mutual fund manager headquartered in Toronto, Canada. The firm was founded in 2000 and they are a subsidiary of Templeton International, Inc. Their ultimate parent is Franklin Resources, Inc. (NYSE: BEN), a global investment management company also known as Franklin Templeton Investments. FTI provides investment advisory and portfolio management services with clients in jurisdictions worldwide, which include registered open-end and closed-end funds and unregistered funds, as well as separate accounts for institutional and high net-worth clients. | Investment Managers | Corporate Officer/Principal | |
| ALLAKOS INC. | Pharmaceuticals: Major | Director/Board Member | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| FRANKLIN RESOURCES, INC. | Investment Managers | Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | Director/Board Member | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| University of California San Diego | College/University | Undergraduate Degree | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Rady Children's Institute for Genomic Medicine | Director/Board Member | ||
Infinant Health, Inc.
 Infinant Health, Inc. BiotechnologyHealth Technology Infinant Health, Inc. develops novel solutions to resolve the dysbiosis. It develops a probiotic bacteria activated with specific prebiotic oligosaccharides and delivery systems to provide and maintain a healthy microbiome in infants during the first six months of life. The company is headquartered in Davis, CA. | Biotechnology | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chairman | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Boston College | College/University | Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Calico LLC
 Calico LLC BiotechnologyHealth Technology Part of Alphabet, Inc., Calico LLC conducts research into the biology of aging. The company is based in South San Francisco, CA. Arthur D. Levinson has been the CEO of the company since 2013. | Biotechnology | Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Universität zu Lübeck | College/University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 37 |
| Verenigd Koninkrijk | 7 |
| Canada | 4 |
| Duitsland | 3 |
| Zweden | 3 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 12 |
| Finance | 6 |
| Health Services | 4 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 71 |
| Independent Dir/Board Member | 36 |
| Corporate Officer/Principal | 33 |
| Chairman | 13 |
| Director of Finance/CFO | 11 |
Sterkste connecties
| Insiders | |
|---|---|
| Catherine Mackey | 24 |
| Luke Beshar | 19 |
| Scott Myers | 18 |
| Paolo Pucci | 15 |
| Michael Kamarck | 15 |
| James Parsons | 10 |
| Jan Skvarka | 10 |
| Paul Walker | 9 |
| Deborah Baron | 9 |
| Helena Tayton-Martin | 8 |
| Jeff Settleman | 7 |
| Kathleen Large | 5 |
| Robert A. Uger | 4 |
| Penka Petrova | 4 |
| Ingmar Bruns | 3 |
- Beurs
- Insiders
- Andrew Muratore
- Bedrijfsconnecties